JPRN-UMIN000045425暂停未知
Pharmacokinetics and efficacy of Vedolizumab in inflammatory bowel diseases - Pharmacokinetics of Vedolizumab in inflammatory bowel diseases
适应症
试验速览
- 阶段
- 未知
- 状态
- 暂停
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 79years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Prospective evaluation of vedolizumab-effects in patients with inflammatory bowel diseasesulcerative colitis and Crohn's diseaseJPRN-UMIN000039916Saitama Medical Center, Saitama Medical University50
撤回
不适用
Efficacy and Safety of vedolizumab in biologic-naïve Korean patients with moderate to severe inflammatory bowel diseaseDiseases of the digestive systemKCT0006087Yonsei University Health System, Severance Hospital60
招募中
不适用
Prospective evaluation of vedolizumab-effects and safety in patients with inflammatory bowel diseases (VED IBD Cohort Study)JPRN-UMIN000040175Saitama Medical Center, Saitama Medical University50
已完成
3 期
Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative ColitisUlcerative ColitisNCT02039505Takeda292
已完成
不适用
Therapeutic drug monitoring of vedolizumab in patients with inflammatory bowel diseaseNL-OMON55193Maxima Medisch Centrum160